CBG Protected Memory in a Schizophrenia Model. The Reason It Worked Wasn’t the One Scientists Expected.
A preclinical study found that repeated CBG treatment prevented a long-term recognition memory impairment induced by MK-801 in male rats, an experimental model used to study cognitive deficits relevant to schizophrenia. The effect did not appear to involve restoring reduced BDNF protein levels, though changes in TrkB messenger RNA point to a possible mechanism that… Keep Reading
